Skip to main content
Top
Published in: BMC Neurology 1/2020

01-12-2020 | Magnetic Resonance Imaging | Case report

Clinical-radiological dissociation in a patient with nitrous oxide-induced subacute combined degeneration: a case report

Authors: Jiwei Jiang, Xiuli Shang

Published in: BMC Neurology | Issue 1/2020

Login to get access

Abstract

Background

Several recent studies have reported subacute combined degeneration (SCD) induced by nitrous oxide (N2O) abuse. However, the association between the evolution of dynamic neuroimaging and clinical manifestations has not been reported in patients with N2O-induced SCD.

Case presentation

We described the case of a 24-year-old man who developed SCD with inverted V-sign hyperintensities over the posterior aspect of the spinal cord caused by frequent, excessive N2O inhalation. One month after treatment, his weakness and paresthesia resolved and serum vitamin B12 levels exceeded the normal levels. However, the hyperintensities had extended horizontally and longitudinally on T2-weighted magnetic resonance imaging (MRI), compared to those on the initial scan. Two months after treatment, the patient experienced some residual numbness in the distal limbs, and his serum homocysteine levels were normal, but the abnormal signals seen on cervical T2-weighted MRI had decreased only slightly compared to those seen on the one-month follow-up MRI. The evolution of conventional MRI findings lagged compared to the clinical manifestation, which was suggestive of a clinical-radiological dissociation.

Conclusions

Clinical-radiological dissociation might have occurred in this case because T2-weighted imaging was not sensitive enough to reveal cytotoxic edema. Moreover, the serum vitamin B12 level is not a good indicator of cellular vitamin B12. Thus, clinicians should recognize this phenomenon, comprehensively assess the condition of patients with N2O-induced SCD, and avoid terminating treatment based on the resolution of clinical symptoms and serological results.
Literature
1.
go back to reference Green R, Allen LH, Bjørke-Monsen AL, Brito A, Guéant JL, Miller JW, et al. Vitamin B12 deficiency. Nat Rev Dis Primers. 2017;3:17040.CrossRef Green R, Allen LH, Bjørke-Monsen AL, Brito A, Guéant JL, Miller JW, et al. Vitamin B12 deficiency. Nat Rev Dis Primers. 2017;3:17040.CrossRef
2.
go back to reference Patel KK, Mejia Munne JC, Gunness VRN, Hersey D, Alshafai N, Sciubba D, et al. Subacute combined degeneration of the spinal cord following nitrous oxide anesthesia: a systematic review of cases. Clin Neurol Neurosurg. 2018;173:163–8.CrossRef Patel KK, Mejia Munne JC, Gunness VRN, Hersey D, Alshafai N, Sciubba D, et al. Subacute combined degeneration of the spinal cord following nitrous oxide anesthesia: a systematic review of cases. Clin Neurol Neurosurg. 2018;173:163–8.CrossRef
3.
go back to reference Cao J, Su ZY, Xu SB, Liu CC. Subacute combined degeneration: a retrospective study of 68 cases with short-term follow-up. Eur Neurol. 2018;79:247–55.CrossRef Cao J, Su ZY, Xu SB, Liu CC. Subacute combined degeneration: a retrospective study of 68 cases with short-term follow-up. Eur Neurol. 2018;79:247–55.CrossRef
4.
go back to reference Jordan JT, Weiser J, Van Ness PC. Unrecognized cobalamin deficiency, nitrous oxide, and reversible subacute combined degeneration. Neurol Clin Pract. 2014;4:358–61.CrossRef Jordan JT, Weiser J, Van Ness PC. Unrecognized cobalamin deficiency, nitrous oxide, and reversible subacute combined degeneration. Neurol Clin Pract. 2014;4:358–61.CrossRef
5.
go back to reference Hathout L, El-Saden S. Nitrous oxide-induced B12 deficiency myelopathy: perspectives on the clinical biochemistry of vitamin B12. J Neurol Sci. 2011;301:1–8.CrossRef Hathout L, El-Saden S. Nitrous oxide-induced B12 deficiency myelopathy: perspectives on the clinical biochemistry of vitamin B12. J Neurol Sci. 2011;301:1–8.CrossRef
6.
go back to reference Hunt A, Harrington D, Robinson S. Vitamin B12 deficiency. BMJ. 2014;349:g5226.CrossRef Hunt A, Harrington D, Robinson S. Vitamin B12 deficiency. BMJ. 2014;349:g5226.CrossRef
7.
go back to reference Briani C, Dalla Torre C, Citton V, Manara R, Pompanin S, Binotto G, et al. Cobalamin deficiency: clinical picture and radiological findings. Nutrients. 2013;5:4521–39.CrossRef Briani C, Dalla Torre C, Citton V, Manara R, Pompanin S, Binotto G, et al. Cobalamin deficiency: clinical picture and radiological findings. Nutrients. 2013;5:4521–39.CrossRef
8.
9.
go back to reference Tian C. Hyperintense signal on spinal cord diffusion-weighted imaging in a patient with subacute combined degeneration. Neurol India. 2011;59:429–31.CrossRef Tian C. Hyperintense signal on spinal cord diffusion-weighted imaging in a patient with subacute combined degeneration. Neurol India. 2011;59:429–31.CrossRef
10.
go back to reference Kim EY, Lee SY, Cha SH, Yi KS, Cho BS, Kang MH. Subacute combined degeneration revealed by diffusion-weighted imaging: a case study. Clin Neuroradiol. 2013;23:157–9.CrossRef Kim EY, Lee SY, Cha SH, Yi KS, Cho BS, Kang MH. Subacute combined degeneration revealed by diffusion-weighted imaging: a case study. Clin Neuroradiol. 2013;23:157–9.CrossRef
11.
go back to reference Simonsen CZ, Madsen MH, Schmitz ML, Mikkelsen IK, Fisher M, Andersen G. Sensitivity of diffusion- and perfusion-weighted imaging for diagnosing acute ischemic stroke is 97.5%. Stroke. 2015;46:98–101.CrossRef Simonsen CZ, Madsen MH, Schmitz ML, Mikkelsen IK, Fisher M, Andersen G. Sensitivity of diffusion- and perfusion-weighted imaging for diagnosing acute ischemic stroke is 97.5%. Stroke. 2015;46:98–101.CrossRef
Metadata
Title
Clinical-radiological dissociation in a patient with nitrous oxide-induced subacute combined degeneration: a case report
Authors
Jiwei Jiang
Xiuli Shang
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2020
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-020-01685-5

Other articles of this Issue 1/2020

BMC Neurology 1/2020 Go to the issue